<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1716">
  <stage>Registered</stage>
  <submitdate>16/10/2007</submitdate>
  <approvaldate>16/10/2007</approvaldate>
  <nctid>NCT00545740</nctid>
  <trial_identification>
    <studytitle>Prevention of Recurrence of Diverticulitis</studytitle>
    <scientifictitle>A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.</scientifictitle>
    <utrn />
    <trialacronym>PREVENT1</trialacronym>
    <secondaryid>2007-004895-37</secondaryid>
    <secondaryid>SPD476-313</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Diverticulitis</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - SPD476 (1.2g)
Treatment: drugs - SPD476 (2.4 g)
Treatment: drugs - SPD476 (4.8 g)
Treatment: drugs - Placebo

Experimental: SPD476 (1.2 g) - 

Experimental: SPD476 (2.4 g) - 

Experimental: SPD476 (4.8 g) - 

Placebo Comparator: Placebo - 


Treatment: drugs: SPD476 (1.2g)
1.2g SPD476 once daily (QD) orally

Treatment: drugs: SPD476 (2.4 g)
2.4g SPD476 QD orally

Treatment: drugs: SPD476 (4.8 g)
4.8g SPD476 QD orally

Treatment: drugs: Placebo
QD orally

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Percent of Subjects Without Recurrence of Diverticulitis - Recurrence of diverticulitis is defined as the presence of each and all of the following 3 items: 1) abdominal pain, 2) a 15% increase in white blood cell count from baseline, 3) bowel wall thickening (&gt;5 mm) and/or fat stranding as evidenced by spiral computerized axial tomography (CT) scan; OR surgical intervention for diverticular disease. Withdrawals are considered as recurrences.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Percent of Subjects Who Were CT-Recurrence Free of Diverticulitis - CT-recurrence of diverticulitis is defined as: a positive spiral CT scan for diverticulitis showing, at a minimum, fat stranding with or without bowel wall thickening &gt;5 mm or surgical intervention for diverticular disease. Withdrawals considered as CT-recurrences.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of CT Scans Performed Within 7 Days of Suspected Recurrence of Diverticulitis That Were Positive - A positive CT scan was defined as a CT scan that showed bowel wall thickening (&gt;5 mm) and/or fat stranding as read by the central reader.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of CT Scans Performed Within 7 Days of Suspected Recurrence of Diverticulitis That Were Negative - A negative CT scan was defined as a CT scan that did not show bowel wall thickening (&gt;5 mm) and/or fat stranding as read by the central reader.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of CT Scans Performed More Than 7 Days From Suspected Recurrence of Diverticulitis That Were Positive - A positive CT scan was defined as a CT scan that showed bowel wall thickening (&gt;5 mm) and/or fat stranding as read by the central reader.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of CT Scans Performed More Than 7 Days From Suspected Recurrence of Diverticulitis That Were Negative - A negative CT scan was defined as a CT scan that did not show bowel wall thickening (&gt;5 mm) and/or fat stranding as read by the central reader.</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Percent of Subjects Requiring Surgery for Diverticulitis</outcome>
      <timepoint>Up to 104 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Males and females =&gt;18yrs of age.

          2. If female of childbearing potential (FOCP), has demonstrated a negative beta HCG
             (human chorionic gonadotropin) serum pregnancy test, and agrees to comply with any
             applicable contraceptive requirements of the protocol.

          3. An episode of acute diverticulitis that resolved without colonic resection.

          4. Confirmation of diverticulosis via endoscopic evaluation of the sigmoid colon with at
             least three diverticula noted.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Previous colorectal surgery, including surgical intervention for diverticular disease
             (with the exception of haemorrhoidectomy, colonic removal of polyps, and appendectomy)

          2. Active peptic ulcer disease

          3. History of or current presence of inflammatory bowel disease (IBD)

          4. Subjects with active irritable bowel syndrome (IBS) requiring ongoing medication

          5. Allergy or hypersensitivity to aspirin or related compounds

          6. Allergy to radiologic contrast agents

          7. Use of another Investigational product within 30 days of Baseline

          8. Use of antibiotic therapy within 4 weeks of Baseline

          9. Within 14 days of Baseline, use of prebiotic, probiotic or 5-ASA medications, as well
             as drugs active at the 5HT-receptor or anti-spasmodic agents

         10. Use of systemic or rectal steroids within 6 weeks of Baseline. Use of inhaled or nasal
             steroids is acceptable

         11. Use of anti-inflammatory drugs, (NSIADs, COX-2 inhibitors) including aspirin (except
             for cardiac prophylaxis) and ibuprofen, on a regular and ongoing basis

         12. History of alcohol or other substance abuse within the previous year

         13. Active or recent history of endometriosis or dysmenorrhoea within 6 months prior to
             Baseline

         14. Females who are lactating</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/11/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>590</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/03/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>ACT,VIC</recruitmentstate>
    <hospital>The Canberra Hospital - Garran</hospital>
    <hospital>Ballarat Base Hospital - Ballarat</hospital>
    <hospital>St Vincent's Hospital (Melb) LTD - Melbourne</hospital>
    <hospital>Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Royal Prince Albert Hospital - Camperdown</hospital>
    <hospital>Frankston Private - Frankston</hospital>
    <hospital>Bayside Gastroenterology - Frankston</hospital>
    <hospital>Fremantle Hospital - Fremantle</hospital>
    <postcode>2605 - Garran</postcode>
    <postcode>3350 - Ballarat</postcode>
    <postcode>3065 - Melbourne</postcode>
    <postcode>5000 - Adelaide</postcode>
    <postcode>2050 - Camperdown</postcode>
    <postcode>3199 - Frankston</postcode>
    <postcode>VIC 3199 - Frankston</postcode>
    <postcode>6160 - Fremantle</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arkansas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Colorado</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Connecticut</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Georgia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Indiana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Iowa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Louisiana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Michigan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Missouri</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Tennessee</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Wisconsin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>Buenos Aires</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>Santa Fe</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Barranquilla</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Bogota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Medellin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Alsace</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Brittany</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Normandy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Paris</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Picardie</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Provence-Alpes-Côte d'Azur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Provence-Alpes-Côte-d'Azur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Rhone-Alpes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Lille</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Kerala</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Punjab</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Rajasthan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Tamil Nadu</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Gujarat</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Kolkatta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Pune</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Secunderabad</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Afula</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Ashkelon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Beer Sheva</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Haifa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Jerusalem</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Kfar-Saba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Petah-Tikva</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Rechovot</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Tel Aviv</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Tel Hashomer</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Zerifin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Dunedin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hamilton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Tauranga</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Barcelona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Palma de Mallorca</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>San Sebastian</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Valencia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Goteborg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Linköping</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Stockholm</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Uppsala</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>East Anglia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>London</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Shire</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine whether SPD476 is effective in reducing recurrence
      of diverticulitis.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00545740</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof. Michael Kamm</name>
      <address>St. Vincent's Medical Center</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>